Helio.com

Among patients with rheumatoid arthritis, those with higher levels of three adipokines demonstrated an increased risk for fracture, according to […]

SAN ANTONIO — The herbal remedy known as kratom, which comes from a tree that grows primarily in Southeast Asia,

CHICAGO — De novo autoimmune diseases, including myositis, vasculitis and lupus, may occur after chimeric antigen receptor T-cell therapy for

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded it

The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and

A cognitive behavioral therapy program delivered by smartphone app improved the mental health and quality of life of people with

SAN ANTONIO — Managing pediatric vasculitis demands special considerations in the clinic, in school and at home, according to a

CHICAGO — Pancytopenia and thrombocytopenia, but not mortality, were elevated in patients with lupus receiving immune checkpoint inhibitor therapy for

CHICAGO — The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with moderate-to-severe plaque

SAN ANTONIO — Stories and analogies can help rheumatology patients understand the complexities of their conditions and improve medication adherence,

Helping patients with lupus navigate disability insurance, so they can maintain care after a job loss, is just one step

CHICAGO — Patients with psoriatic arthritis who received GLP-1 receptor agonists exhibited lower risks for mortality and cardiovascular events vs.

CHICAGO — More than 30% of patients with rheumatic disease, and more than 40% of those with rheumatoid arthritis, experienced

CHICAGO — Patients with diabetes who used GLP-1 receptor agonists demonstrated lower risks for certain rheumatic diseases, including rheumatoid arthritis

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to

When I first read about walking meetings, or those that take place while on a walk in lieu of a

CHICAGO — Although overall mortality rates for patients with lupus have declined since the turn of the century, racial, sex

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a pair of “timely

CHICAGO — A machine learning model can use patient-reported data and remote therapeutic monitoring to accurately assess low disease activity

I recently had the privilege of speaking at the Advances in Rheumatology and Technologies Symposium (ARTS), held in Chicago on

Postmenopausal women using hormone therapy were more likely to develop autoimmune diseases compared with nonusers, research presented at the Annual

CHICAGO — Self-care and taking time to enjoy “sacred moments” can help reduce burnout and improve work-life balance for physicians,

JAMA and the JAMA Network launched a new resource centered entirely on women’s health, consolidating the high-quality research from across

Women can use simple strategies to build each other up and level the playing field in medical leadership, according to

NASHVILLE — It is a “scary time” to be a medical student amid new AI technology and distrust in health

Editor’s note: This is a developing news story. Please check back soon for updates.President Donald J. Trump announced an agreement

The FDA approved a supplemental new drug application for Tremfya for the treatment of children aged 6 years or older